Editorial: Somatostatin: newcomer from the hypothalamus.
D000172:Acromegaly / Q000188:drug therapy; D000236:Adenoma / Q000188:drug therapy; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002415:Cats; D003920:Diabetes Mellitus / Q000188:drug therapy; D004285:Dogs; D005934:Glucagon / Q000097:blood; D013006:Growth Hormone / Q000037:antagonists & inhibitors / Q000097:blood; D013007:Growth Hormone-Releasing Hormone / Q000037:antagonists & inhibitors*; D000882:Haplorhini; D006801:Humans; D007031:Hypothalamus / Q000032:analysis; D007328:Insulin / Q000097:blood; D010215:Papio; D010455:Peptides / Q000494:pharmacology* / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000188:drug therapy; D011388:Prolactin / Q000097:blood; D051381:Rats; D012756:Sheep; D013972:Thyrotropin / Q000037:antagonists & inhibitors; D014020:Tissue Extracts / Q000494:pharmacology
D001786:Blood Glucose; D007328:Insulin; D010455:Peptides; D014020:Tissue Extracts; D011388:Prolactin; D013972:Thyrotropin; D013006:Growth Hormone; D005934:Glucagon; D013007:Growth Hormone-Releasing Hormone